ARIJIT SAMANTA

Employment

• Aliah University PhD Student
  2021 - Present

Education

• St Xavier's University Integrated M.Sc.
  2015 - 2020

Projects & Funding

Projects & funding information is unavailable.

Publications (30)

• Integrated High-Throughput Virtual Screening and Molecular Dynamics Approach to Identify Potential PD-1 Inhibitors for Cancer Immunotherapy
  Journal of Computational Biophysics and Chemistry 2026 DOI: 10.1142/S2737416526500559
  +Save
• Mapping Pharmacological Network to Identify Common Molecular Targets of Epigallocatechin-3-gallate (EGCG) in Inflammation and Cancer
  Journal of Computational Biophysics and Chemistry 2026 DOI: 10.1142/S2737416526500304
  +Save
• Damaging non-synonymous mutations in the extracellular domain of HER2 potentially alter the efficacy of Herceptin-mediated breast cancer therapy
  Egyptian Journal of Medical Human Genetics 2025 DOI: 10.1186/s43042-025-00775-8
  +Save
• High throughput data: Single-nucleotide polymorphisms in depth
  Systems Biology and In-Depth Applications for Unlocking Diseases 2025 DOI: 10.1016/b978-0-443-22326-6.00009-2
  +Save
• Immunoinformatics based designing of a multi-epitope cancer vaccine targeting programmed cell death ligand 1
  Scientific Reports 2025 DOI: 10.1038/s41598-025-87063-y
  +Save
• Recent advances and future prospects of adoptive cell-based cancer immunotherapy
  Molecular Medicine and Biomedical Research in the Era of Precision Medicine 2025 DOI: 10.1016/b978-0-443-22300-6.00051-6
  +Save
• Structural insights into the impacts of non-synonymous single nucleotide polymorphisms in CD274 gene on the PD-1/PD-L1 interaction: An in silico approach
  Biochemical and Biophysical Research Communications 2025 DOI: 10.1016/j.bbrc.2025.152679
  +Save
• Systems biology of cancer
  Systems Biology and In-Depth Applications for Unlocking Diseases 2025 DOI: 10.1016/b978-0-443-22326-6.00023-7
  +Save
• Systems vaccinology
  Systems Biology and In-Depth Applications for Unlocking Diseases 2025 DOI: 10.1016/b978-0-443-22326-6.00018-3
  +Save
• Lateral flow assay for SARS-CoV-2 infection: Uses and limitations
  2024 DOI: 10.1016/B978-0-323-95650-5.00039-2
  +Save